Market Overview

ImmunoGen, Inc. (NASDAQ: IMGN)

2.31 +0.06 (2.67%)

Earnings

QuarterPriorEstimateActualSurprise
Q2 2020
Pre-Market
EPS:
REV:




Q1 2020
Pre-Market
EPS:
REV:
-0.30
8.584M



Q4 2019
Pre-Market
EPS:
REV:
-0.28
13.786M



Q3 2019
Pre-Market
EPS:
REV:
-0.32
10.928M



Q2 2019
Pre-Market
EPS:
REV:
-0.31
9.287M
-0.33
9.48M
-0.29
15.542M
12.12%
63.95%
Q1 2019
Pre-Market
EPS:
REV:
-0.30
19.815M
-0.21
10.59M
-0.30
8.584M
-42.86%
-18.94%
Q4 2018
Pre-Market
EPS:
REV:
-0.11
39.448M
-0.32
12.27M
-0.28
13.786M
-12.5%
12.36%
Q3 2018
Pre-Market
EPS:
REV:
-0.37
8.48M
-0.31
13.84M
-0.32
10.928M
3.23%
-21.04%
Q2 2018
Pre-Market
EPS:
REV:
-0.10
39.02M
-0.29
13.92M
-0.31
9.287M
6.9%
-33.28%
Q1 2018
Pre-Market
EPS:
REV:
-0.20
28.686M
-0.24
15.04M
-0.30
19.815M
25%
31.75%

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!